Cartesian Therapeutics, Inc. - Common Stock (RNAC)

$24.47 3.02 (14.08%)
14:51 EDT RNAC Stock Quote Delayed 30 Minutes

RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings
RNAC stock results show that Cartesian Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q4 2023

Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.) 69,826
Day's Range $21.59 - $25.10
52-Week Range $0.47 - $27.29
Dividend & Yield N/A (N/A)